As the higher doses of MPCs a well tolerated and offer better results MSB should instigate another phase 2 trial of two much higher doses. Like most physical, biological and chemical systems there will be at some point flatting out of improvement relative to the dose applied. However it possible that the higher dose in the last phase 2 is nowhere near that point.
- Forums
- ASX - By Stock
- MSB
- BP update - R.A.
MSB
mesoblast limited
Add to My Watchlist
2.17%
!
$1.65

BP update - R.A., page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.65 |
Change
0.035(2.17%) |
Mkt cap ! $2.105B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $3.028M | 1.849M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 15024 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.65 | 24823 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 17222 | 1.645 |
14 | 49206 | 1.640 |
12 | 80706 | 1.635 |
11 | 98181 | 1.630 |
11 | 97543 | 1.625 |
Price($) | Vol. | No. |
---|---|---|
1.650 | 35112 | 19 |
1.655 | 89891 | 16 |
1.660 | 94117 | 10 |
1.665 | 89761 | 15 |
1.670 | 138984 | 10 |
Last trade - 11.27am 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online